Cerebras (CBRS)

The reviews on Cerebras (CBRS-Q) present a mixed perspective regarding its recent performance and market position. One expert noted that the IPO was not recommended due to the initial overvaluation, leading to a significant price drop from an earlier peak of $160, despite a recent recovery to $221. Meanwhile, another review highlights the strength of the business itself but emphasizes that the IPO price was excessively high, resulting in shares losing about a third of their value. There is a consensus that while the company has potential, the current stock price remains elevated, suggesting that caution is warranted for potential investors. Overall, the sentiment reflects a combination of skepticism and recognition of the company's value proposition.